NCT02024152View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Acute Urticaria
Interventions
DRUG

JDP-205 IV high dose

DRUG

JDP-205 IV low dose

DRUG

JDP-205 IM

DRUG

Control: Zyrtec

Trial Locations (1)

Unknown

Algorithme Pharma, Montreal

Sponsors

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

JDP Therapeutics, Inc.

INDUSTRY